Showing results (111-120 of 192) with videos related to

Sort By:
Pageof 20
Diagnostic Microbiology and Infectious Disease|November 26, 2008
Identification of Pseudomonas aeruginosa by a duplex real-time polymerase chain reaction assay targeting the ecfX and the gyrB genesSnehal N Anuj, David M Whiley, Timothy J Kidd, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|July 18, 2025
The changing face of cystic fibrosis research: challenges of multi-centre microbiology cohort studiesIeuan Es Evans, Christine M Duplancic, Timothy A Kidd, et al.
British Journal of Clinical Pharmacology|November 1, 2006
A d-optimal designed population pharmacokinetic study of oral itraconazole in adult cystic fibrosis patientsStefanie Hennig, Timothy H Waterhouse, Scott C Bell, et al.
Clinical Therapeutics|April 24, 2026
Lumacaftor-Ivacaftor in Pediatric Patients With Cystic Fibrosis and Advanced Liver Disease: A Pilot StudyAdeline Y L Lim, Maria P Hernández-Mitre, Peter J Lewindon, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|September 5, 2018
Differential expression of genes and receptors in monocytes from patients with cystic fibrosisAbdullah A Tarique, Peter D Sly, Diana G Cardenas, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 5, 2025
Improvements in health-related quality of life in people with cystic fibrosis ≥6 years of age treated with vanzacaftor/tezacaftor/deutivacaftorClaire E Wainwright, Teja Thorat, Sarah Conner, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 29, 2011
Aztreonam for inhalation solution (AZLI) in patients with cystic fibrosis, mild lung impairment, and P. aeruginosaC E Wainwright, A L Quittner, D E Geller, et al.
Thorax|December 31, 2005
Controlled longitudinal study of bone mass accrual in children and adolescents with cystic fibrosisH M Buntain, P J Schluter, S C Bell, et al.
Pageof 20